
    
      (A) Establish a High-purity isolation of CTCs to NGS platform within one year

      (B) Design a Prospective trial (CTCNGS01 at www.clinicaltrials.gov) utilizing the developed
      technique to elucidate the baseline CTC-NGS information to cancer tissue NGS.
    
  